Clinical trial
Effects Of Prednisolone On Rheumatoid Arthritis Patients
NCT00330889 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00330889 |
|---|---|
| Title | Effects Of Prednisolone On Rheumatoid Arthritis Patients |
| Official title | A Study of the Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Arthritis, Rheumatoid |
| Enrollment | 32 |
| Start date | Feb 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | May 29, 2006 |
| Last update posted | Oct 22, 2012 |
| Countries | Canada, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: